Source: European Medicines Agency (EU) Revision Year: 2018 Publisher: Helsinn Birex Pharmaceuticals Limited, Damastown, Mulhuddart, Dublin 15, Ireland
Aloxi 500 micrograms soft capsules.
| Pharmaceutical Form |
|---|
|
Soft capsule. Plain, light beige, opaque, round to oval, soft gelatine capsules, filled with a clear yellowish solution. |
Each capsule contains 500 micrograms palonosetron (as hydrochloride).
Excipient(s): Each capsule contains 7 mg sorbitol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Palonosetron |
Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor. |
| List of Excipients |
|---|
|
Capsule content: Glycerol monocaprylocaproate (type I) Capsule shell: Gelatin |
Polyamide/aluminium/PVC blister containing one or five soft capsules.
Not all pack sizes may be marketed.
Helsinn Birex Pharmaceuticals Limited, Damastown, Mulhuddart, Dublin 15, Ireland
EU/1/04/306/003
EU/1/04/306/002
Date of first authorisation: 22 March 2005
Date of latest renewal: 23 March 2010
| Drug | Countries | |
|---|---|---|
| ALOXI | Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
